Skip to content
ParamountParamount Inc. Tokyo, Japan
Dry Susp.

Keflo-4

50 mg/5 ml

Cefdinir

Segment 05 · Cephalosporins

Keflo-450 mg/5 ml

Dry Suspension

Cefdinir

Dry Susp.

Keflo-4

50 mg/5 ml

Cefdinir

Third generation cephalosporin for respiratory and skin infections.

Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation

Generic composition
Cefdinir
Strength
50 mg/5 ml
Dosage form
Dry Suspension
Pack sizes
60 ml

Other forms & strengths of Keflo-4

Manufacturer
Paramount Pharmaceuticals, Islamabad
Licence
DML 000439 · DRAP GMP
Release
Batch-tested, with Certificate of Analysis

For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.

Keflo-4

How it's made

Dry suspensions are made as a dry powder blend, filled into bottles; water is added only when the medicine is dispensed. Made in the segregated cephalosporin section, which has its own air handling and material flows.

How all our dosage forms are made →
  1. 01

    Dispensing

    Each raw material is released by QC, then weighed for the batch under a second person's check.

  2. 02

    Dry blending

    The active ingredient is blended with sweeteners, flavour and suspending agents as a dry powder.

  3. 03

    Powder filling

    Bottles are filled to a set powder weight; water is added only by the pharmacist or patient.

  4. 04

    Capping and labelling

    Bottles are sealed and labelled with the batch number and expiry date.

Batch release tests

  • Fill weight
  • Assay of the active ingredient
  • Reconstitution and pH
  • Water content
  • Microbial limits

Limits for this product are on each batch's Certificate of Analysis.